A detailed history of Black Rock Inc. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 10,392,636 shares of SUPN stock, worth $375 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,392,636
Previous 10,362,356 0.29%
Holding current value
$375 Million
Previous $353 Million 21.35%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$25.99 - $33.85 $786,977 - $1.02 Million
30,280 Added 0.29%
10,392,636 $278 Million
Q1 2024

May 10, 2024

SELL
$27.11 - $35.17 $553,423 - $717,960
-20,414 Reduced 0.2%
10,362,356 $353 Million
Q4 2023

Feb 13, 2024

BUY
$22.72 - $29.68 $4.61 Million - $6.02 Million
202,865 Added 1.99%
10,382,770 $300 Million
Q3 2023

Nov 13, 2023

BUY
$27.57 - $32.91 $6.05 Million - $7.22 Million
219,482 Added 2.2%
10,179,905 $281 Million
Q2 2023

Aug 11, 2023

BUY
$29.91 - $38.73 $13.8 Million - $17.9 Million
461,053 Added 4.85%
9,960,423 $299 Million
Q1 2023

May 12, 2023

SELL
$34.93 - $42.03 $3.69 Million - $4.44 Million
-105,522 Reduced 1.1%
9,499,370 $344 Million
Q4 2022

Feb 13, 2023

BUY
$31.09 - $37.88 $12.1 Million - $14.7 Million
388,318 Added 4.21%
9,604,892 $343 Million
Q3 2022

Nov 14, 2022

BUY
$28.79 - $35.41 $12.1 Million - $14.9 Million
420,429 Added 4.78%
9,216,574 $312 Million
Q2 2022

Aug 12, 2022

SELL
$25.33 - $34.25 $2.37 Million - $3.2 Million
-93,430 Reduced 1.05%
8,796,145 $254 Million
Q1 2022

May 12, 2022

BUY
$28.51 - $32.9 $12.5 Million - $14.4 Million
438,553 Added 5.19%
8,889,575 $287 Million
Q4 2021

Feb 10, 2022

SELL
$26.37 - $34.22 $10.8 Million - $14 Million
-407,715 Reduced 4.6%
8,451,022 $246 Million
Q3 2021

Nov 09, 2021

SELL
$23.54 - $31.39 $313,435 - $417,957
-13,315 Reduced 0.15%
8,858,737 $236 Million
Q2 2021

Aug 11, 2021

BUY
$26.72 - $33.19 $237 Million - $294 Million
8,872,052 New
8,872,052 $273 Million

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.93B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.